130 related articles for article (PubMed ID: 16803569)
41. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
42. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.
Chrzanowska KH; Piekutowska-Abramczuk D; Popowska E; Gładkowska-Dura M; Małdyk J; Syczewska M; Krajewska-Walasek M; Goryluk-Kozakiewicz B; Bubała H; Gadomski A; Gaworczyk A; Kazanowska B; Kołtan A; Kuźmicz M; Luszawska-Kutrzeba T; Maciejka-Kapuścińska L; Stolarska M; Stefańska K; Sznurkowska K; Wakulińska A; Wieczorek M; Szczepański T; Kowalczyk J
Int J Cancer; 2006 Mar; 118(5):1269-74. PubMed ID: 16152606
[TBL] [Abstract][Full Text] [Related]
43. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
45. Inactivation of the Nijmegen breakage syndrome gene leads to excess centrosome duplication via the ATR/BRCA1 pathway.
Shimada M; Sagae R; Kobayashi J; Habu T; Komatsu K
Cancer Res; 2009 Mar; 69(5):1768-75. PubMed ID: 19244116
[TBL] [Abstract][Full Text] [Related]
46. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
[TBL] [Abstract][Full Text] [Related]
47. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
[TBL] [Abstract][Full Text] [Related]
48. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
[TBL] [Abstract][Full Text] [Related]
49. A rare polymorphic variant of NBS1 reduces DNA repair activity and elevates chromosomal instability.
Yamamoto Y; Miyamoto M; Tatsuda D; Kubo M; Nakagama H; Nakamura Y; Satoh H; Matsuda K; Watanabe T; Ohta T
Cancer Res; 2014 Jul; 74(14):3707-15. PubMed ID: 24830725
[TBL] [Abstract][Full Text] [Related]
50. [Mutations in tumor suppressor gene NBS1 in adult patients with malignancies].
Seemanová E; Hoch J; Herzogová J; Kawaciuk I; Janda J; Kohoutová M; Seeman P; Varon R; Sperling K
Cas Lek Cesk; 2006; 145(3):201-3. PubMed ID: 16634478
[TBL] [Abstract][Full Text] [Related]
51. Association of ionizing radiation-induced foci of NBS1 with chromosomal instability and breast cancer susceptibility.
Someya M; Sakata K; Tauchi H; Matsumoto Y; Nakamura A; Komatsu K; Hareyama M
Radiat Res; 2006 Oct; 166(4):575-82. PubMed ID: 17007554
[TBL] [Abstract][Full Text] [Related]
52. Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.
Tokunaga E; Okada S; Kitao H; Shiotani S; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
Breast Cancer; 2011 Apr; 18(2):120-3. PubMed ID: 19813073
[TBL] [Abstract][Full Text] [Related]
53. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
[TBL] [Abstract][Full Text] [Related]
54. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.
Strathdee G; Holyoake TL; Sim A; Parker A; Oscier DG; Melo JV; Meyer S; Eden T; Dickinson AM; Mountford JC; Jorgensen HG; Soutar R; Brown R
Clin Cancer Res; 2007 Sep; 13(17):5048-55. PubMed ID: 17785556
[TBL] [Abstract][Full Text] [Related]
55. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
56. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
57. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
[TBL] [Abstract][Full Text] [Related]
58. Conditional inactivation of the NBS1 gene in the mouse central nervous system leads to neurodegeneration and disorganization of the visual system.
Baranes K; Raz-Prag D; Nitzan A; Galron R; Ashery-Padan R; Rotenstreich Y; Assaf Y; Shiloh Y; Wang ZQ; Barzilai A; Solomon AS
Exp Neurol; 2009 Jul; 218(1):24-32. PubMed ID: 19345213
[TBL] [Abstract][Full Text] [Related]
59. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
60. The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.
D'Andrea AD
Cell Cycle; 2003; 2(4):290-2. PubMed ID: 12851475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
